NCT02074358 A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02068053 Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020 Status COMPLETED Phase PHASE1
NCT02067910 Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome Status COMPLETED Phase PHASE3
NCT02066636 A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Status COMPLETED Phase PHASE3
NCT02061761 A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT02060188 A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread Status COMPLETED Phase PHASE2
NCT02048865 Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients Status COMPLETED Phase PHASE2
NCT02047149 Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia Status TERMINATED Phase PHASE1
NCT02046733 Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease Status COMPLETED Phase PHASE2
NCT02045966 Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02041533 An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) Status COMPLETED Phase PHASE3
NCT02038946 Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) Status COMPLETED Phase PHASE2
NCT02038933 Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) Status COMPLETED Phase PHASE2
NCT02037737 Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting Status COMPLETED Phase N/A
NCT02034838 Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study Status COMPLETED Phase PHASE1
NCT02034656 Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA) Status UNKNOWN Phase N/A
NCT02034591 Phase 1 Oral Solution and Crushed Tablet Relative Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects Status COMPLETED Phase PHASE1